Literature DB >> 10098989

A computer model of the spread of hepatitis C virus among injecting drug users.

D Mather1, N Crofts.   

Abstract

A number of behavioural and clinical parameters influence the transmission of an infectious agent through direct contact between two individuals. The behavioural parameters encountered in such situations are also likely to exhibit an enormous amount of variability. With the spread of hepatitis C among injecting drug users, the parameters associated with injecting behaviour play an important role in the modelling of the transmission process. Computer simulation modelling is an ideal approach to deal with a large number of parameters as well as high levels of variability without excessive simplification. The simulation model presented in this paper is tested on data from a cohort of injecting drug users and the results obtained are very encouraging from a public health perspective. The model clearly indicates that the rate at which HCV spreads through a population of injecting drug users is extremely sensitive to the interaction rate and to the probability of infection through a single contact with an infective. At the same time it shows that rate of spread is not very sensitive to initial prevalence, which is very encouraging from a public health perspective.

Entities:  

Mesh:

Year:  1999        PMID: 10098989     DOI: 10.1023/a:1007548307196

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 2.  To C or not to C: these are the questions.

Authors:  H J Alter
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

Review 3.  Transmission of hepatitis C virus: rates, routes, and cofactors.

Authors:  M MacDonald; N Crofts; J Kaldor
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

4.  Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.

Authors:  N Crofts; C K Aitken
Journal:  Med J Aust       Date:  1997-07-07       Impact factor: 7.738

5.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 6.  Epidemiology of hepatitis C virus infection among injecting drug users in Australia.

Authors:  N Crofts; D Jolley; J Kaldor; I van Beek; A Wodak
Journal:  J Epidemiol Community Health       Date:  1997-12       Impact factor: 3.710

7.  Differences in the hepatitis C virus genotypes in different countries.

Authors:  N Takada; S Takase; A Takada; T Date
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

Review 8.  Occupational health in surgery: risks extend beyond the operating room.

Authors:  J A Patz; D Jodrey
Journal:  Aust N Z J Surg       Date:  1995-09

9.  Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease.

Authors:  F E Preston; L M Jarvis; M Makris; L Philp; J C Underwood; C A Ludlam; P Simmonds
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

10.  Variable infectiousness in HIV transmission models.

Authors:  S P Blythe; R M Anderson
Journal:  IMA J Math Appl Med Biol       Date:  1988
View more
  9 in total

1.  Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users.

Authors:  H A Pollack
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.

Authors:  Judith A Hahn; Dennis Wylie; Jesse Dill; Maria S Sanchez; James O Lloyd-Smith; Kimberly Page-Shafer; Wayne M Getz
Journal:  Epidemics       Date:  2009-03       Impact factor: 4.396

3.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 4.  Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.

Authors:  Ashley B Pitcher; Annick Borquez; Britt Skaathun; Natasha K Martin
Journal:  J Theor Biol       Date:  2018-11-16       Impact factor: 2.691

Review 5.  Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Authors:  Nick Scott; Margaret Hellard; Emma Sue McBryde
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

Review 6.  A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.

Authors:  Meghan Bellerose; Lin Zhu; Liesl M Hagan; William W Thompson; Liisa M Randall; Yelena Malyuta; Joshua A Salomon; Benjamin P Linas
Journal:  Int J Drug Policy       Date:  2019-11-15

7.  Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections.

Authors:  Alexander Gutfraind; Basmattee Boodram; Nikhil Prachand; Atesmachew Hailegiorgis; Harel Dahari; Marian E Major
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

8.  Per-Contact Infectivity of Hepatitis C Virus Acquisition in Association With Receptive Needle Sharing Exposures in a Prospective Cohort of Young Adult People who Inject Drugs in San Francisco, California.

Authors:  Yuridia Leyva; Kimberly Page; Stephen Shiboski; Judith A Hahn; Jennifer Evans; Erik Erhardt
Journal:  Open Forum Infect Dis       Date:  2020-03-16       Impact factor: 3.835

9.  Hepatitis C transmission and treatment in contact networks of people who inject drugs.

Authors:  David A Rolls; Rachel Sacks-Davis; Rebecca Jenkinson; Emma McBryde; Philippa Pattison; Garry Robins; Margaret Hellard
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.